Amid the ongoing opioid crisis, a U.S. lawmaker is pressing a professional medical society that also functions as a patient advocacy group to disclose detailed information about its ties to drug makers over concerns it tried to sway government moves to curb opioid prescribing.

In a March 12 letter, Sen. Ron Wyden (D-Ore.) instructed the American Academy of Pain Medicine to provide a raft of documents, including tax filings; a list of payments from drug and device makers made to the group and its top officer; information about work performed for opioid maker Purdue Pharma; continuing medical education coursework; and its conflict of interest policy, among other things.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy